Journal articles on the topic 'JAK2 46/1 haplotype'
Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles
Consult the top 50 journal articles for your research on the topic 'JAK2 46/1 haplotype.'
Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.
You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.
Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.
Jones, Amy V., Peter J. Campbell, Philip A. Beer, Susanne Schnittger, Alessandro M. Vannucchi, Katerina Zoi, Melanie J. Percy, et al. "The JAK2 46/1 haplotype predisposes to MPL-mutated myeloproliferative neoplasms." Blood 115, no. 22 (June 3, 2010): 4517–23. http://dx.doi.org/10.1182/blood-2009-08-236448.
Full textAl-Ammari, Maged, Abdul Ali Peer Zada, Ibraheem H. Motabi, Belal M. Albtoosh, Syed Y. Altaf, Imran K. Tailor, Mohammed S. Alnoamani, et al. "JAK2 GGCC (46/1) Haplotype in Unprovoked Venous Thrombotic Events." Blood 138, Supplement 1 (November 5, 2021): 4258. http://dx.doi.org/10.1182/blood-2021-149560.
Full textCross, Nicholas C. P., Amy V. Jones, Richard T. Silver, David Oscier, Georgia Metzgeroth, Y. Lynn Wang, Andrew Collins, Andreas Reiter, Francis Grand, and Andrew Chase. "Development of V617F JAK2 Associated Myeloproliferative Neoplasms Is a Non-Random Event That Is Strongly Dependent on JAK2 Haplotype." Blood 112, no. 11 (November 16, 2008): 173. http://dx.doi.org/10.1182/blood.v112.11.173.173.
Full textCross, Nicholas C. P., Peter Campbell, Philip A. Beer, Susanne Schnittger, Alessandro M. Vannucchi, Katerina Zoi, Melanie Percy, et al. "The JAK2 46/1 Haplotype Predisposes to Myeloproliferative Neoplasms Characterized by Diverse Mutations." Blood 114, no. 22 (November 20, 2009): 433. http://dx.doi.org/10.1182/blood.v114.22.433.433.
Full textVilaine, Mathias, Damla Olcaydu, Ashot Harutyunyan, Jonathan Bergeman, Tiab Mourad, Jean-François Ramée, Jian-Min Chen, Robert Kralovics, and Sylvie Hermouet. "Homologous Recombination of Wild TYPE JAK2, A NOVEL EARLY STEP In the DEVELOPMENT of Myeloproliferative Neoplasm." Blood 118, no. 21 (November 18, 2011): 2805. http://dx.doi.org/10.1182/blood.v118.21.2805.2805.
Full textOlkhovskiy, I. А., M. A. Stolyar, Yu Yu Komarovskiy, A. S. Gorbenko, V. I. Korchagin, E. A. Dunaeva, K. O. Mironov, et al. "Study of the Janus kinase 2 (JAK2) gene haplotype 46/1 association with driver mutations of chronic Ph-negative myeloproliferative neoplasms." Russian journal of hematology and transfusiology 67, no. 3 (October 22, 2022): 377–87. http://dx.doi.org/10.35754/0234-5730-2022-67-3-377-387.
Full textSmalberg, Jasper, Edith Koehler, Sarwa Darwish Murad, Aurelie Plessier, Juan-Carlos Garcia-Pagan, Susana Seijó, Philippe Langlet, et al. "JAK2 Germline Genetic Variation In Budd-Chiari Syndrome and Portal Vein Thrombosis." Blood 116, no. 21 (November 19, 2010): 4212. http://dx.doi.org/10.1182/blood.v116.21.4212.4212.
Full textSmalberg, Jasper H., Edith Koehler, Sarwa Darwish Murad, Aurelie Plessier, Susana Seijo, Jonel Trebicka, Massimo Primignani, et al. "The JAK2 46/1 haplotype in Budd-Chiari syndrome and portal vein thrombosis." Blood 117, no. 15 (April 14, 2011): 3968–73. http://dx.doi.org/10.1182/blood-2010-11-319087.
Full textKouroupi, Eirini, Jean-Jacques Kiladjian, Christine Chomienne, Christine Dosquet, Sylvia Bellucci, Dominique Valla, and Bruno Cassinat. "The JAK2 46/1 haplotype in splanchnic vein thrombosis." Blood 117, no. 21 (May 26, 2011): 5777–78. http://dx.doi.org/10.1182/blood-2011-03-343657.
Full textTefferi, Ayalew, Terra L. Lasho, Christy Finke, Mythri Mudireddy, Natasha Szuber, Rangit Reddy Vallapureddy, Domenico Penna, et al. "The Germline JAK2 GGCC (46/1) Haplotype and Survival Among 414 Molecularly-Annotated Patients with Primary Myelofibrosis." Blood 132, Supplement 1 (November 29, 2018): 1761. http://dx.doi.org/10.1182/blood-2018-99-110046.
Full textHasan, Salma, Jean Pierre Le Couedic, Fabrizia Favale, Barbara Monte-Mor, Catherine Lacout, Nicole Casadevall, Eric Solary, Jean-Luc Villeval, Isabelle Plo, and William Vainchenker. "46/1 Haplotype Permits to Follow JAK2 Homologous Recombination: Modeling JAK2V617F clonal Architecture in PV Patients." Blood 120, no. 21 (November 16, 2012): 1757. http://dx.doi.org/10.1182/blood.v120.21.1757.1757.
Full textVannucchi, Alessandro M., and Paola Guglielmelli. "The JAK2 46/1 (GGCC ) MPN-predisposing haplotype: A risky haplotype, after all." American Journal of Hematology 94, no. 3 (December 18, 2018): 283–85. http://dx.doi.org/10.1002/ajh.25367.
Full textLea, Nicholas C., Lara N. Roberts, Raj K. Patel, Rachel Westbrook, Michael A. Heneghan, Azim M. Mohamedali, Alex E. Smith, et al. "Prevalence of 46/1 JAK2 Haplotype in Patients with Budd-Chiari Syndrome with and without JAK2V617F and TET2 Mutations." Blood 114, no. 22 (November 20, 2009): 434. http://dx.doi.org/10.1182/blood.v114.22.434.434.
Full textPanovska, Irina, Nadica Matevska, Martin Ivanovski, Sanja Trajkova, Dusko Dukovski, Lidija Cevreska, and Aleksandar Dimovski. "Frequency and Clinical Correlates of JAK2 46/1 Haplotype in Comparison with JAK2V617F Variant in Myeloproliferative Neoplasms: Single Center Experience." Blood 118, no. 21 (November 18, 2011): 5173. http://dx.doi.org/10.1182/blood.v118.21.5173.5173.
Full textKouroupi, Eirini G., Bruno Cassinat, Aurelie Plessier, Sylvia Bellucci, Christine Chomienne, Bernard Granchamp, Dominique Valla, and Jean-Jacques Kiladjian. "Lack of Association Between the 46/1 JAK2 Haplotype and the Presence of JAK2V617F Mutation In Splanchnic Vein Thrombosis Patients." Blood 116, no. 21 (November 19, 2010): 4120. http://dx.doi.org/10.1182/blood.v116.21.4120.4120.
Full textAngona, Anna, Beatriz Bellosillo, Alberto Alvarez-Larrán, Luz Maria Martinez-Aviles, Laura Camacho, Silvia Pairet, Concepción Fernández, and Carles Besses. "Genetic Predisposition to Molecular Response in Patients with Myeloproliferative Neoplasms Treated with Hydroxycarbamide." Blood 120, no. 21 (November 16, 2012): 1738. http://dx.doi.org/10.1182/blood.v120.21.1738.1738.
Full textPacilli, Annalisa, Paola Guglielmelli, Tiziana Fanelli, Alessandro Pancrazzi, Lisa Pieri, Rajmonda Fjerza, and Alessandro M. Vannucchi. "JAK2V617F Clonal Architecture in MPNs during JAK2 Inhibitor Treatment." Blood 126, no. 23 (December 3, 2015): 1630. http://dx.doi.org/10.1182/blood.v126.23.1630.1630.
Full textMacedo, L. C., B. C. Santos, S. Pagliarini-e-Silva, K. B. B. Pagnano, C. Rodrigues, F. C. Quintero, M. E. Ferreira, et al. "JAK2 46/1 haplotype is associated with JAK2 V617F - positive myeloproliferative neoplasms in Brazilian patients." International Journal of Laboratory Hematology 37, no. 5 (May 11, 2015): 654–60. http://dx.doi.org/10.1111/ijlh.12380.
Full textTanaka, Mayumi, Toshiaki Yujiri, Shunsuke Ito, Naoko Okayama, Toru Takahashi, Kenji Shinohara, Yoichi Azuno, Ryouhei Nawata, Yuji Hinoda, and Yukio Tanizawa. "JAK2 46/1 haplotype is associated with JAK2 V617F-positive myeloproliferative neoplasms in Japanese patients." International Journal of Hematology 97, no. 3 (February 22, 2013): 409–13. http://dx.doi.org/10.1007/s12185-013-1295-y.
Full textPaes, Jhemerson, George A. V. Silva, Andréa M. Tarragô, and Lucivana P. de Souza Mourão. "The Contribution of JAK2 46/1 Haplotype in the Predisposition to Myeloproliferative Neoplasms." International Journal of Molecular Sciences 23, no. 20 (October 20, 2022): 12582. http://dx.doi.org/10.3390/ijms232012582.
Full textMahmood, Shameem, Louise Mellish, Nicholas Lea, Austin G. Kulasekararaj, Atiyeh Abdallah, Sivatharsny Srirangan, and Ghulam J. Mufti. "The JAK2 46/1 Haplotype Analysis In Essential Thrombocythaemia and Polycythaemia Rubra Vera Reveals That CC Genotype Is Associated with a Higher JAK2V617F and c-MPL W515 Allele Burden." Blood 116, no. 21 (November 19, 2010): 1977. http://dx.doi.org/10.1182/blood.v116.21.1977.1977.
Full textZagaria, Antonella, Francesco Tarantini, Luisa Anelli, Paola Orsini, Angela Minervini, Nicoletta Coccaro, Elisa Parciante, et al. "JAK2 Negative Erythrocytosis Associated with JAK2 GGCC_46/1 Haplotype, Calr rs1049481_G, and Normal Erythropoietin Level: Is This a New Entity?" Blood 136, Supplement 1 (November 5, 2020): 28. http://dx.doi.org/10.1182/blood-2020-139450.
Full textCampiotti, Leonardo, Lorenzo Elli, Matteo B. Suter, Luigina Guasti, and Francesco Pallotti. "JAK2, 46/1 haplotype and chronic myelogenous leukemia: diagnostic and therapeutic potential." Clinical Chemistry and Laboratory Medicine (CCLM) 58, no. 1 (December 18, 2019): e24-e26. http://dx.doi.org/10.1515/cclm-2019-0158.
Full textAndrikovics, H., S. Nahajevszky, M. Koszarska, N. Meggyesi, A. Bors, G. Halm, S. Lueff, et al. "JAK2 46/1 haplotype analysis in myeloproliferative neoplasms and acute myeloid leukemia." Leukemia 24, no. 10 (September 2, 2010): 1809–13. http://dx.doi.org/10.1038/leu.2010.172.
Full textStolyar, M. A., O. A. Klimova, A. S. Gorbenko, E. V. Brenner, S. E. Titov, M. K. Ivanov, and I. A. Olkhovskiy. "JAK2 haplotype 46/1 and JAK2 V617F allele burden in MPN: New evidence against the “hypermutability” hypothesis?" International Journal of Laboratory Hematology 40, no. 1 (November 14, 2017): e8-e10. http://dx.doi.org/10.1111/ijlh.12765.
Full textWang, Hui, Guixiang Sun, Peijin Zhang, Jing Zhang, Er Gui, Maoheng Zu, Enzhi Jia, et al. "JAK2 V617F mutation and 46/1 haplotype in Chinese Budd-Chiari syndrome patients." Journal of Gastroenterology and Hepatology 29, no. 1 (December 19, 2013): 208–14. http://dx.doi.org/10.1111/jgh.12379.
Full textZerjavic, Katja, Boris Zagradisnik, Lidija Lokar, Marjana G. Krasevac, and Nadja K. Vokac. "The association of the JAK2 46/1 haplotype with non-splanchnic venous thrombosis." Thrombosis Research 132, no. 2 (August 2013): e86-e93. http://dx.doi.org/10.1016/j.thromres.2013.06.021.
Full textSoler, G., A. Bernal-Vicente, A. I. Antón, J. M. Torregrosa, E. Caparrós-Pérez, I. Sánchez-Serrano, A. Martínez-Pérez, B. Sánchez-Vega, V. Vicente, and F. Ferrer-Marin. "The JAK2 46/1 haplotype does not predispose to CALR-mutated myeloproliferative neoplasms." Annals of Hematology 94, no. 5 (December 9, 2014): 789–94. http://dx.doi.org/10.1007/s00277-014-2266-y.
Full textGuglielmelli, P., F. Biamonte, A. Spolverini, L. Pieri, A. Isgrò, E. Antonioli, A. Pancrazzi, A. Bosi, G. Barosi, and A. M. Vannucchi. "Frequency and clinical correlates of JAK2 46/1 (GGCC) haplotype in primary myelofibrosis." Leukemia 24, no. 8 (June 3, 2010): 1533–37. http://dx.doi.org/10.1038/leu.2010.126.
Full textHasan, Salma, Bruno Cassinat, Jean-Pierre Le Couédic, Fabrizia Favale, Barbara Monte-Mor, Catherine Lacout, Eric Solary, et al. "Use Of 46/1 Haplotype Permits To Follow JAK2V617F Clonal Architecture In PV Patients: Clonal Evolution and Impact Of IFNα Treatment." Blood 122, no. 21 (November 15, 2013): 4109. http://dx.doi.org/10.1182/blood.v122.21.4109.4109.
Full textPatnaik, M. M., T. L. Lasho, C. M. Finke, N. Gangat, D. Caramazza, S. Siragusa, C. A. Hanson, A. Pardanani, and A. Tefferi. "MPL mutation effect on JAK2 46/1 haplotype frequency in JAK2V617F-negative myeloproliferative neoplasms." Leukemia 24, no. 4 (January 28, 2010): 859–60. http://dx.doi.org/10.1038/leu.2010.1.
Full textTrifa, Adrian P., Andrei Cucuianu, Ljubomir Petrov, Laura Urian, Mariela S. Militaru, Delia Dima, Ioan V. Pop, and Radu A. Popp. "The G allele of the JAK2 rs10974944 SNP, part of JAK2 46/1 haplotype, is strongly associated with JAK2 V617F-positive myeloproliferative neoplasms." Annals of Hematology 89, no. 10 (April 27, 2010): 979–83. http://dx.doi.org/10.1007/s00277-010-0960-y.
Full textSpolverini, Ambra, Amy V. Jones, Andreas Hochhaus, Lisa Pieri, Nicholas C. P. Cross, and Alessandro M. Vannucchi. "The myeloproliferative neoplasm-associated JAK2 46/1 haplotype is not overrepresented in chronic myelogenous leukemia." Annals of Hematology 90, no. 3 (June 16, 2010): 365–66. http://dx.doi.org/10.1007/s00277-010-1009-y.
Full textTrifa, Adrian P., Sorin Crişan, Radu A. Popp, Andrei Cucuianu, and Anca D. Buzoianu. "JAK2 46/1 haplotype seems not to be associated with lower limb deep venous thrombosis." Blood Cells, Molecules, and Diseases 45, no. 3 (October 2010): 199–200. http://dx.doi.org/10.1016/j.bcmd.2010.07.004.
Full textWang, J., Z. Xu, L. Liu, R. P. Gale, N. C. P. Cross, A. V. Jones, T. Qin, et al. "JAK2V617F allele burden, JAK2 46/1 haplotype and clinical features of Chinese with myeloproliferative neoplasms." Leukemia 27, no. 8 (January 22, 2013): 1763–67. http://dx.doi.org/10.1038/leu.2013.21.
Full textZhang, Xinju, Tingting Hu, Zhiyuan Wu, Zhihua Kang, Weiwei Liu, and Ming Guan. "The JAK2 46/1 haplotype is a risk factor for myeloproliferative neoplasms in Chinese patients." International Journal of Hematology 96, no. 5 (September 29, 2012): 611–16. http://dx.doi.org/10.1007/s12185-012-1169-8.
Full textCleyrat, Cédric, Jaroslav Jelinek, François Girodon, Marjorie Boissinot, Thierry Ponge, Jean-Luc Harousseau, Jean-Pierre Issa, Sylvie Hermouet, and Sylvie Hermouet. "Polycythemia Vera with Multiple Clones Carrying Different Mutations (L611V, V617F, L611V/V617F) in Exon 14 of JAK2." Blood 114, no. 22 (November 20, 2009): 3908. http://dx.doi.org/10.1182/blood.v114.22.3908.3908.
Full textVillani, Laura, Gaetano Bergamaschi, Massimo Primignani, Vittorio Rosti, Adriana Carolei, Valentina Poletto, Paolo Catarsi, Ambra Spolverini, Alessandro M. Vannucchi, and Giovanni Barosi. "JAK2 46/1 haplotype predisposes to splanchnic vein thrombosis-associated BCR-ABL negative classic myeloproliferative neoplasms." Leukemia Research 36, no. 1 (January 2012): e7-e9. http://dx.doi.org/10.1016/j.leukres.2011.08.008.
Full textTefferi, Ayalew, Terra L. Lasho, Mythri Mudireddy, Christy M. Finke, Curtis A. Hanson, Rhett P. Ketterling, Naseema Gangat, and Animesh Pardanani. "The germline JAK2 GGCC (46/1) haplotype and survival among 414 molecularly-annotated patients with primary myelofibrosis." American Journal of Hematology 94, no. 3 (December 5, 2018): 299–305. http://dx.doi.org/10.1002/ajh.25349.
Full textPagliarini e Silva, S., BC Santos, EM Pereira, ME Ferreira, EC Baraldi, AM Sell, and JE Visentainer. "Evaluation of the association between the JAK2 46/1 haplotype and chronic myeloproliferative neoplasms in a Brazilian population." Clinics 68, no. 1 (January 28, 2013): 5–9. http://dx.doi.org/10.6061/clinics/2013(01)oa02.
Full textBendaly, Edmond A., Saud S. Rahman, Samiah Zafar, Karen Haglof, Sherif Ibrahim, and Bruce G. Raphael. "Is JAK2 Inducible by Cytotoxic Chemotherapy?" Blood 114, no. 22 (November 20, 2009): 4979. http://dx.doi.org/10.1182/blood.v114.22.4979.4979.
Full textAlvarez-Larrán, Alberto, Anna Angona, Luz Martínez-Avilés, Beatriz Bellosillo, and Carlos Besses. "Influence of JAK2 46/1 haplotype in the natural evolution of JAK2V617F allele burden in patients with myeloproliferative neoplasms." Leukemia Research 36, no. 3 (March 2012): 324–26. http://dx.doi.org/10.1016/j.leukres.2011.09.029.
Full textNguyen, Huong (Marie), and Jason Gotlib. "Insights into the Molecular Genetics of Myeloproliferative Neoplasms." American Society of Clinical Oncology Educational Book, no. 32 (June 2012): 411–18. http://dx.doi.org/10.14694/edbook_am.2012.32.85.
Full textLi, Sheng-li, Pei-jin Zhang, Gui-xiang Sun, and Zhao-jun Lu. "The JAK2 46/1 haplotype (GGCC) in myeloproliferative neoplasms and splanchnic vein thrombosis: a pooled analysis of 26 observational studies." Annals of Hematology 93, no. 11 (July 13, 2014): 1845–52. http://dx.doi.org/10.1007/s00277-014-2134-9.
Full textTefferi, A., T. L. Lasho, M. M. Patnaik, C. M. Finke, K. Hussein, W. J. Hogan, M. A. Elliott, M. R. Litzow, C. A. Hanson, and A. Pardanani. "JAK2 germline genetic variation affects disease susceptibility in primary myelofibrosis regardless of V617F mutational status: nullizygosity for the JAK2 46/1 haplotype is associated with inferior survival." Leukemia 24, no. 1 (October 22, 2009): 105–9. http://dx.doi.org/10.1038/leu.2009.225.
Full textIrvin-Barnwell, Elizabeth A., Ajay Yesupriya, Miyono Hendrix, Vince Seaman, Sean Mochal, Stanimila Nikolova, Ronald Hoffman, Steve Dearwent, and Suzanne Cordovado. "Prevalence Of The JAK2V617F Mutation and Associated Risk Haplotype and Determination Of Demographic and Lifestyle Risk Factors In The US Population, Nhanes 1999-2002." Blood 122, no. 21 (November 15, 2013): 391. http://dx.doi.org/10.1182/blood.v122.21.391.391.
Full textWang, Linghua, Sabina Swierczek, Kimberly Hickman, Soo-Jin Kim, David A. Wheeler, and Josef Prchal. "Molecular Characterization Of Polycythemia Vera Based On The Relationship Of JAK2V617F and 9pUPD." Blood 122, no. 21 (November 15, 2013): 1607. http://dx.doi.org/10.1182/blood.v122.21.1607.1607.
Full textMartínez-Trillos, Alejandra, Margherita Maffioli, Dolors Colomer, Alberto Alvarez-Larrán, Arturo Pereira, Anna Angona, Beatriz Bellosillo, and Francisco Cervantes. "Relationship between the 46/1 haplotype of the JAK2 gene and the JAK2 mutational status and allele burden, the initial findings, and the survival of patients with myelofibrosis." Annals of Hematology 93, no. 5 (December 15, 2013): 797–802. http://dx.doi.org/10.1007/s00277-013-1989-5.
Full textGau, Jyh-Pyng, Chih-Cheng Chen, Yi-Sheng Chou, Chia-Jen Liu, Yuan-Bin Yu, Liang-Tsai Hsiao, Jin-Hwang Liu, et al. "No increase of JAK2 46/1 haplotype frequency in essential thrombocythemia with CALR mutations: Functional effect of the haplotype limited to allele with JAK2V617F mutation but not CALR mutation." Blood Cells, Molecules, and Diseases 55, no. 1 (June 2015): 36–39. http://dx.doi.org/10.1016/j.bcmd.2015.03.009.
Full textMead, Adam J., Michelle Rugless, Petter Woll, Ruth Clifford, Debbie Atkinson, Simon Moule, Nicola Bienz, et al. "Germline Activating JAK2 V617I Mutation in a Family with Hereditary Thrombocytosis." Blood 118, no. 21 (November 18, 2011): 1738. http://dx.doi.org/10.1182/blood.v118.21.1738.1738.
Full text